DR ANTHONY MELVIN CRASTO,WorldDrugTracker, helping millions, A 90 % paralysed man in action for you, I am suffering from transverse mylitis and bound to a wheel chair, With death on the horizon, nothing will not stop me except God................DR ANTHONY MELVIN CRASTO Ph.D ( ICT, Mumbai) , INDIA 25Yrs Exp. in the feld of Organic Chemistry,Working for GLENMARK GENERICS at Navi Mumbai, INDIA. Serving chemists around the world. Helping them with websites on Chemistry.Million hits on google, world acclamation from industry, academia, drug authorities for websites, blogs and educational contribution
Showing posts with label methyl 2-amino-5-iodo-4-trifluoromethylbenzoate.. Show all posts
Showing posts with label methyl 2-amino-5-iodo-4-trifluoromethylbenzoate.. Show all posts

Thursday, 12 March 2015

Methyl 2-amino-5-iodo-4-trifluoromethylbenzoate.


Figure imgf000058_0002





https://www.google.com/patents/WO2006002342A1?cl=en

 Preparation of methyl 2-amino-5-iodo-4-trifluoromethylbenzoate.
Figure imgf000058_0002
Add a solution of methyl 2-amino-4-trifluoromethylbenzoate (178 g, 812 mmol) in ethanol (3.3 L) to a suspension of iodine (206.1 g, 812 mmol) and silver(II) sulfate (253 g, 812 mmol) in ethanol (5 L) at room temperature under an atmosphere of nitrogen and stir for 2 h. Filter the suspension through a pad of a Celite®, wash the pad with additional ethanol (2 L) and remove the solvents from the combined filtrates under reduced pressure at 40 °C. Dissolve the residue in ethyl acetate (7.5 L) and wash with saturated sodium bicarbonate solution (3 X 1.5 L), water (3 X 1.5 L) and brine (2 L). Dry the organic phase over anhydrous magnesium sulfate, filter and remove the solvent under reduced pressure to give the title compound as a pale brown crystalline solid (276.0 g, 99%). 1H NMR (300 MHz, CDCl3) D 
8.39 (1 H, s), 
6.99 (1 H, s), 
5.93 (2 H, s), NH2
3.90 (3 H, s).